Free Access
Vet. Res.
Volume 39, Number 4, July-August 2008
Prion diseases in animals
Number of page(s) 13
Published online 15 February 2008
How to cite this article Vet. Res. (2008) 39:32
References of Vet. Res. 39 (2008) 321-13
  1. Aguzzi A., Heikenwalder M., Pathogenesis of prion diseases: current status and future outlook, Nat. Rev. Microbiol. (2006) 4:765–775.
  2. Andréoletti O., Berthon P., Levavasseur E., Lantier F., Monks E., Elsen J.M., Schelcher F., Phenotyping of protein-prion (PrPSc)-accumulating cells in lymphoid and neural tissues of naturally scrapie-affected sheep by double-labeling immunohistochemistry, J. Histochem. Cytochem. (2002) 50:1357–1370.
  3. Asante E.A., Linehan J.M., Desbruslais M., Joiner S., Gowland I., Wood A.L., et al., BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein, EMBO J. (2002) 21:6358–6366.
  4. Asante E.A., Linehan, J. M., Gowland I., Joiner S., Fox K., Cooper S., et al., Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice, Proc. Natl. Acad. Sci. USA (2006) 103:10759–10764.
  5. Beekes M., Baldauf E., Diringer H., Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie, J. Gen. Virol. (1996) 77:1925–1934.
  6. Beringue V., Bencsik A., Le Dur A., Reine F., Lai T.L., Chenais N., et al., Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy, PLoS Pathog. (2006) 2:956–963.
  7. Béringue V., Andréoletti O., Le Dur A., Essalmani R., Vilotte J.L., Lacroux C., et al., A bovine prion acquires an epidemic bovine spongiform encephalopathy strain-like phenotype on interspecies transmission, J. Neurosci. (2007) 27:6965–6871.
  8. Al Bersaoui R., Robert I., Lutz Y., Blanc F., Sommermeyer-Leroux G., Shibaguchi H., et al., Purkinje-cell degeneration in prion protein-deficient mice is associated with a cerebellum-specific Doppel protein species signature, FEBS Lett. (2005) 9:2715–2721.
  9. Bishop M.T., Hart P., Aitchison L., Baybutt H.N., Plinston C., Thomson V., et al., Predicting susceptibility and incubation time of human-to-human transmission of vCJD, Lancet Neurol. (2006) 5:393–398.
  10. Borchelt D.R., Davis J., Fischer M., Lee M.K., Slunt H.H., Ratovitsky T., et al., A vector for expressing foreign genes in the brains and hearts of transgenic mice, Genet. Anal. (1996) 13:159–163.
  11. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., et al., Normal host prion protein necessary for scrapie-induced neurotoxicity, Nature (1996) 379:339–343.
  12. Brandner S., Raeber A., Sailer A., Blättler T., Fischer M., Weissmann C., Aguzzi A., Normal host protein (PrP$^{\rm C})$ is required for scrapie spread within the central nervous system, Proc. Natl. Acad. Sci. USA (1996) 93:13148–13151.
  13. Browning S.R., Mason G.L., Seward T., Green M., Eliason G.A., Mathiason C., et al., Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP, J. Virol. (2004) 78:13345–13350.
  14. Bruce M.E., Mc Connell I., Fraser H., Dickinson A.G., The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis, J. Gen. Virol. (1991) 72:595–603.
  15. Bruce M.E., Scrapie strain variation and mutation, Br. Med. Bull. (1993) 49:822–838.
  16. Bruce M.E., Boyle A., Cousens S., McConnell I., Foster J., Goldmann W., Fraser H., Strain characterization of natural sheep scrapie and comparison with BSE, J. Gen. Virol. (2002) 83:695–704.
  17. Bruce M.E., TSE strain variation, Br. Med. Bull. (2003) 66:99–108.
  18. Brun A., Gutierrez-Adan A., Castilla J., Pintado B., Segundo F.D.S., Cano M.J., et al., Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats, J. Gen. Virol. (2007) 88:1842–1849.
  19. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., et al., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein, Nature (1992) 356:577–582.
  20. Buschmann A., Pfaff E., Reifenberg K., Muller H.M., Groschup M.H., Detection of cattle-derived BSE prions using transgenic mice overexpressing bovine PrP(C), Arch. Virol. Suppl. (2000) 16:75–86.
  21. Buschmann A., Groschup M.H., Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle, J. Infect. Dis. (2005) 192:934–942.
  22. Cancelotti E., Wiseman F., Tuzi N.L., Baybutt H., Monaghan P., Aitchison L., et al., Altered glycosylated PrP proteins can have different neuronal trafficking in brain but do not acquire scrapie-like properties, J. Biol. Chem. (2005) 280:42909–42918.
  23. Cancellotti E., Barron R.M., Bishop M.T., Hart P., Wiseman F., Manson J.C., The role of host PrP in transmissible spongiform encephalopathies, Biochim. Biophys. Acta (2007) 1772:673–680.
  24. Capobianco R., Casalone C., Suardi S., Manieri M., Miccolo C., Limido L., et al., Conversion of the BASE prion strani into the BSE strani: the origin of BSE?, PLoS Pathog. (2007) 3:31.
  25. Carlson G.A., Ebeling C., Yang S.L., Telling G., Torchia M., Groth D., et al., Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice, Proc. Natl. Acad. Sci. USA (1994) 91:5690–5694.
  26. Cartoni C., Schinina M.E., Maras B., Nonno R., Vaccari G., Di Baria M.A., et al., Identification of the pathological prion protein allotypes in scrapie-infected heterozygous bank voles (Clethrionomys glareolus) by high-performance liquid chromatography-mass spectrometry, J. Chromatogr. A (2005) 1081:122–126.
  27. Castilla J., Gutierrez A.A., Brun A., Pintado B., Ramirez M.A., Parra B., et al., Early detection of PrP(res) in BSE-infected bovine PrP transgenic mice, Arch. Virol. (2003) 148:677–691.
  28. Castilla J., Gutierrez-Adan A., Brun A., Doyle D., Pintado B., Ramirez M.A., et al., Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein, J. Neurosci. (2004) 24:5063–5069.
  29. Chandler R.L., Encephalopathy in mice produced by inoculation with scrapie-brain material, Lancet (1961) 1:1378–1379.
  30. Chandler R.L., Turfrey B.A., Inoculation of voles, Chinese hamsters, gerbils and guinea-pigs with scrapie brain material, Res. Vet. Sci. (1972) 13:219–224.
  31. Collinge J., Clarke A.R., A general model of prion strains and their pathogenecity, Science (2007) 318:930–936.
  32. Cordier C., Bencsik A., Philippe S., Betemps D., Ronzon F., Calavas D., et al., Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59), J. Gen. Virol. (2006) 87:3763–3771.
  33. Crozet C., Flamant F., Bencsik A., Aubert D., Samarut J., Baron T., Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene, J. Virol. (2001) 75:5328–5334.
  34. Dong J., Li A., Yamaguchi N., Sakaguchi S., Harris D.A., Doppel induces degeneration of cerebellar Purkinje cells independently of Bax, Am. J. Pathol. (2007) 171:599–607.
  35. Espinosa J.C., Andréoletti O., Castilla J., Herva M.E., Morales M., Alamillo E., et al., Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice, J. Virol. (2007) 81:835–843.
  36. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., et al., Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie, EMBO J. (1996) 15:1255–1264.
  37. Flechsig E., Shmerling D., Hegyi I., Raeber A.J., Fischer M., Cozzio A., et al., Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice, Neuron (2000) 27:399–408.
  38. Fraser H., Dickinson A.G., Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation, J. Comp. Pathol. (1973) 83:29–40.
  39. Glatzel M., Aguzzi A., PrP$^{\rm C}$ expression in the peripheral nervous system is a determinant of prion neuroinvasion, J. Gen. Virol. (2000) 81:2813–2821.
  40. Gonzalez L., Chianini F., Martin S., Siso S., Gibbard L., Reid H.W., Jeffrey M., Comparative titration of experimental ovine BSE infectivity in sheep and mice, J. Gen. Virol. (2007) 88:714–717.
  41. Gorfe A.A., Caflisch A., Ser170 controls the conformational multiplicity of the loop 166–175 in prion proteins: implication for conversion and species barrier, FASEB J. (2007) 21:3279–3287.
  42. Groschup M.H., Geissen M., Buschmann A., The experimental transmissibility of prions and infectivity distribution in the body, in: Hoernlimann B., Riesner D., Kretzschmar H. (Eds.), Prions in humans and animals, De Gruyter Berlin, New York, 2007, pp. 473–482.
  43. Groschup M.H., Lacroux C., Buschmann A., Lühken G., Mathey J., Eiden M., et al., Classical scrapie in sheep with the ARR/ARR prion genotype in Germany and France, Emerging Infect. Dis. (2007) 13:1201–1207.
  44. Hedge R.S., Masrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., et al., A transmembrane form of the prion protein in neurodegenerative disease, Science (1998) 279:827–834.
  45. Houston E.F., Halliday S.I., Jeffrey M., Goldmann W., Hunter N., New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1), J. Gen. Virol. (2002) 83:1247–1250.
  46. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., Prusiner S.B., Spontaneous neurodegeneration in transgenic mice with mutant prion protein, Science (1990) 250:1587–1590.
  47. Jeffrey M., Begara-McGorum I., Clark S., Martin S., Clark J., Chaplin M., Gonzales L., Occurrence and distribution of infection-specific PrP in tissues of clinical scrapie cases and cull sheep from scrapie-affected farms in Shetland, J. Comp. Pathol. (2002) 127:264–273.
  48. Kercher L., Favara C., Striebel J.F., LaCasse R., Chesebro B., Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina of transgenic mice, J. Virol. (2007) 81:10340–10351.
  49. Kimberlin R.H., Cole S., Walker C.A., Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters, J. Gen. Virol.(1987) 68:1875–1881.
  50. Kong Q., Huang S., Zou W., Vanegas D., Wang M., Wu D., et al., Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models, J. Neurosci. (2005) 25:7944–7949.
  51. Kupfer L., Eiden M., Buschmann A., Groschup M.H., Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras, Biochim. Biophys. Acta (2006) 1772:704–713.
  52. Lasmezas C.I., Deslys J.-P., Robain O., Jaegly A., Béringue V., Peyrin J.M., et al., Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein, Science (1997) 275:402–405.
  53. LaFauci G., Carp R.I., Meeker H.C., Ye X., Kim J.I., Natelli M., et al., Passage of chronic wasting disease prion into transgenic mice expressing Rocky Mountain elk (Cervus elaphus nelsoni) PrPC, J. Gen. Virol. (2006) 87:3773–3780.
  54. Langeveld J.P.M., Jacobs J.G., Erkens J.H.F., Bossers A., van Zijderfeld F.G., van Keulen L.J.M., Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep, BMC Vet. Res. (2006) 2:19.
  55. Laude H., Vilette D., Le Dur A., Archer F., Soulier S., Besnard N., Essalmani R., Vilotte J.L., New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives, C. R. Acad. Sci. III, Sci. Vie (2002) 325:49–57.
  56. Li A., Piccardo P., Barmada S.J., Ghetti B., Harris D.A., Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice, EMBO J. (2007) 6:2777–2785.
  57. Li A., Christensen H.M., Stewart L.R., Roth K.A., Chiesa R., Harris D.A., Neonathal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125, EMBO J. (2007) 26:548–558.
  58. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G., Collinge J., Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration, EMBO J. (2002) 21:202–210.
  59. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., Collinge J., Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis, Science (2003) 302:871–874.
  60. Manson J.C., Jamieson E., Baybutt H., Tuzi N.L., Barron R., McConnell I., et al., A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible songiform encephalopathy, EMBO J. (1999) 18:6855–6864.
  61. Meade-White K., Race B., Trifilo M., Bossers A., Favara C., LaCasse R. et al., Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein, J. Virol. (2007) 81:4533–4539.
  62. Moore R.C., Hope J., McBride P.A., McConnell I., Selfridge J., Melton D.W., Manson J.C., Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent, Nat. Genet. (1998) 18:118–125.
  63. Muramoto T., DeArmond S.J., Scott M., Telling G.C., Cohen F., Prusiner S.B., Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an $\alpha $-helix, Nat. Med. (1997) 3:750–755.
  64. Neuendorf E., Weber A., Saalmüller A., Schätzl H., Reifenberg K., Pfaff E., Groschup M.H., Glycosylation deficiency at either one of the two glycan attachement sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections, J. Biol. Chem. (2004) 279:53306–53316.
  65. Nishida N., Tremblay P., Sugimoto T., Shigematsu K., Shirabe S., Petromilli C., et al., A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelinisation, Lab. Invest. (1999) 79:689–697.
  66. Nonno R., Di Bari M.A., Cardone F., Vaccai G., Fazzi P., Dell'omo G., et al., Efficient transmission and characterization of Creutzfeldt-Jacob disease strains in bank voles, PLoS Pathog. (2006) 2:112–120.
  67. Piccardo P., Manson J.C., King D., Ghetti B., Barron R.M., Accumulation of prion protein in the brain that is not associated with transmissible disease, Proc. Natl. Acad. Sci. USA (2007) 104:4712–4717.
  68. Prusiner S.B., Novel proteinaceous infectious particles cause scrapie, Science (1982) 216:136–144.
  69. Qin K., O'Donnell M., Zhao R.Y., Doppel: more rival than double to prion, Neuroscience (2006) 141:1–8.
  70. Race R.E., Priola S.A., Bessen R.A., Ernst D., Dockter J., Rall G.F., et al., Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent, Neuron (1995) 15:1183–1191.
  71. Race R., Oldstone M., Chesebro B., Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen, J. Virol. (2000) 74:828–833.
  72. Raeber A.J., Sailer A., Hegyi I., Klein M.A., Rülicke T., Fischer M., et al., Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication, Proc. Natl. Acad. Sci. USA (1999) 96:3987–3992.
  73. Safar J.G., Geschwind M.D., Deering C., Didorenko S., Sattavat M., Sanchez H., et al., Diagnosis of human prion disease, Proc. Natl. Acad. Sci. USA (2005) 102:3501–3506.
  74. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., et al., Transgenic mice expressing hamster prion protein produce species- specific scrapie infectivity and amyloid plaques, Cell (1989) 59:847–857.
  75. Scott M. Kohler R., Foster D., Prusiner S.B., Chimeric prion protein expression in cultured cells and transgenic mice, Protein Sci. (1992) 1:986–997.
  76. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., Prusiner S.B., Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes, Cell (1993) 73:979–988.
  77. Scott M.R., Safar J., Telling G., Nguyen O., Groth D., Torchia M., et al., Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice, Proc. Natl. Acad. Sci. USA (1997) 94:14279–14284.
  78. Shmerling D., Hegyi I., Fischer M., Blättler T., Brandner S., Götz J., et al., Expression ofamino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions, Cell (1998) 93:203–214.
  79. Silveira J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., Caughey, B., The most infectious prion protein particles, Nature (2005) 437:257–261.
  80. Supattapone S., Bosque P., Muramoto T., Wille, H. Aagaard C., Peretz D., et al., Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice, Cell (1999) 96:869–878.
  81. Tamguney G., Giles K., Bouzamondo-Bernstein E., Bosque P.J., Miller M.W., Safar J., et al.,Transmission of elk and deer prions to transgenic mice, J. Virol. (2006) 80:9104–9114.
  82. Telling G.C., Scott M. Hsiao K.K., Foster D., Yang S.L., Torchia M., et al., Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein, Proc. Nat. Acad. Sci. U. S. A. (1994) 91:9936–9940.
  83. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., et al., Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein, Cell (1995) 83:79–90.
  84. Vilotte J.L., Soulier S., Essalmani R., Stinnakre M.G., Vaiman D., Lepourry L., et al., Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP, J. Virol. (2001) 75:5977–5984.
  85. Vilotte J.L., Laude H., Transgenesis applied to transmissible spongiform encephalopathies, Transgenic Res. (2002) 11:547–564.
  86. Weissmann C., Flechsig E., PrP knock-out and PrP transgenic mice in prion research, Br. Med. Bull. (2003) 66:43–60.
  87. Wells G.A., Konold T., Arnold M.E., Austin A.R., Hawkins S.A., Stack M., et al., Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle, J. Gen. Virol. (2007) 88:1363–1373.
  88. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.L., et al., Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild- type prion proteins, Cell (1994) 76:117–129.
  89. Windl O., Buchholz M., Neubauer A., Schulz-Schaeffer W., Groschup M., Walter S., et al., Breaking an absolute species barrier: transgenic mice expressing the mink PrP gene are susceptible to transmissible mink encephalopathy, J. Virol. (2005) 79:14971–14975.
  90. Zlotnik I., Stamp J.T., Scrapie in a Dorset Down ram. A confirmation of the histological diagnosis by means of intracerebral inoculation of mice with formol fixed brain tissue, Vet. Rec. (1965) 77:1178–1179.